Exelixis Inc at Barclays Global Healthcare Conference Transcript
Good afternoon. Welcome to Barclays Global Healthcare Conference in Miami. Just e-mail me if you have any questions that need addressed. My name is Peter Lawson. I'm one of the SMID-cap biotech analyst at Barclays. I'm really delighted to have on stage with us the management team from Exelixis, Peter Lamb, Chief Scientific Officer; and Andrew Peters, Chief of Strategy. So thank you so much today for your time.
Questions & Answers
And I guess maybe the first question just around the cabozantinib franchise. It's been a fantastic growth engine cash generator for the company, just like -- kind of the puts and pulls -- pushes and pulls we should think about for '23 and the priorities around cabozantinib and then we kind of -- so I'll ask other questions around the deeper in the franchise.
Yes,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
